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ABSTRACT
For decades several authors have directed their efforts to elucidate the nature of the immune response in periodontitis. The subject has been matter 
of controversy, and answers remain unclear. The present review intends to summarize the character of the inflammatory response in periodontitis, with 
emphasis on the T helper imbalance produced during the development of the disease.
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Nature of the inflammatory response in periodontitis
 Periodontitis encompass multifactorial diseases involving 
bacterial biofilms and the generation of an inflammatory response(1). 
Periodontitis, chronic and aggressive subtypes, is usually related to 
polybacterial infection and three specific pathogens have been repeat-
edly identified as etiologic agents in the periodontal destruction: Aggre-
gatibacter (Actinobacillus) actinomycetemcomitans (Aa), Porphyrom-
onas gingivalis (Pg) y Tannerella forsythia (Tf)(2). Bacterial biofilms have 
been shown to be the primary aetiological factor in the initiation of gin-
gival inflammation and subsequent destruction of periodontal tissues(3). 
Although chronic bacterial and endotoxin exposure is a prerequisite 
for gingival inflammation and periodontal tissue destruction to occur, 
its presence alone accounts for a relatively small proportion (i.e. 20%) 
of the variance in disease expression(4). According to a novel model of 
pathogenesis of periodontitis, this is not sufficient to explain disease 
initiation and progression(5,6,7). The major component of soft- and hard- 
tissue destruction associated with periodontitis is the result of activation 
of the host’s immune-inflammatory response to the bacterial challenge, 
it is the nature of the inflammatory responses which determines the 
destructive character of the disease(8).
 Based upon histopathological features, inflammatory process-
es developed in the periodontitis may be divided into three phases: an 
acute phase, an immune response and a chronic phase(5). The transition 
process from gingival health to early inflammatory changes is character-
ized by a local increase in vascular permeability, redness, swelling and 
by the recruitment and activation of polymorphonuclear granulocytes 
(PMNs)(9). In the course of this acute phase, several products modu-
late vasodilatation (e.g. bradykinin and prostaglandins), vascular per-
meability (e.g. histamine and leukotriene) and additional recruitment of 
inflammatory cells through chemotaxis (e.g. complements products and 
chemokines)(5). The subsequent immune response starts when antigen-
presenting cells become involved presenting the foreign microorga-
nisms or antigens to immunocompetent cells such as T lymphocytes. 
This leads to the expansion of antibody-secreting plasma cells and the 
development of a chronic lesion(10).
Response TH1 vs. TH2 in periodontitis
 Based on their pioneer work, Mosmann and Coffman pro-
posed that T helper cells could be divided into two distinct subsets, T 
helper type 1 (TH1) and TH2, characterized by distinct cytokine profiles 
and effectors functions (11). TH1 cells secrete interferon gamma (IFN-γ) 
and tumor necrosis factor alpha (TNF-α), which are critical for the eradi-
cation of intracellular pathogens, while Th2 cells produce interleukin-4, 
-5, -6, and -13, which are essential for optimal antibody production and 
elimination of extracellular microorganisms, including helminths and 
nematodes(12).
 Immunohistological studies have clearly established that a T-
cell/macrophage lesion identical to a delayed hypersensitivity reaction(13) 
occurs within 4 to 8 days of plaque accumulation in an experimental 
gingivitis study(14). This synonymous with the early lesion described 
by Page and Schroeder(15) and with the putative stable lesion(16). The 
striking similarities between this early/stable periodontal lesions and 
delayed-type hypersensitivity prompted the suggestion that cells with a 
TH1 cytokine profile are the major mediators. Such a concept is consis-
tent with the proposal that a strong innate immune response leads to 
the production of IL-12, which in turn leads to this TH1 response(8). The 
dominance of B-cells/plasma cells in the advanced/progressive lesion 
would suggest a role for TH2 cells. Clearly, if the innate response is 
poor, low levels of IL-12 would be produced and a poor TH1 response 
may occur which may not then contain the infection(17).
 To test this hypothesis, several investigators have attempted 
to delineate the TH1/TH2 profile in periodontal disease. Pilon et al.(18) 
demonstrated lower levels of IL-2 in the gingival crevicular fluid of pe-
riodontitis sites compared with healthy sites, and Fujihashi et al(19) have 
shown that gingival mononuclear cells from adult periodontitis patients 
produce IL-4 and IL-5 but not IL-2. Peripheral blood mononuclear cells 
from periodontitis patients stimulated with mitogens resulted in reduced 
IFN-γ secretion and mRNA expression of IFN-γ and IL-2. At the same 
time, significantly higher levels of IL-5 and granulocyte/macrophage-
colony stimulating factor (GM-CSF) were observed(20). Significantly less 
IL-2 activity was also found in peripheral blood mononuclear cell cul-
tures stimulated with P. gingivalis and F. nucleatum(21). Increased Th2 re-
sponse in periodontitis has also been reported. Memory T-cells from the 
peripheral blood of adult periodontitis patients with high anti- P. gingivalis 
titers stimulated in vitro with P. gingivalis have been shown to produce 
higher amounts of IL-4 than cells from healthy subjects(22). Yamazaki et 
al.(23) demonstrated an increase percentage of IL-4+ cells proportional 
to an increasing B-cell/T-cell ratio. Another study suggested a role for 
IL-4 and TH2 responses in periodontitis lesions by the demonstration 
of concentrations of IgG4 many times higher in sites of active perio-
dontitis than in serum, as well as significantly elevated concentrations 
compared with stable lesions(24). Seymour et al.(25) proposed that due to 
the shift in lymphocyte populations in the inflammatory infiltrate from 
predominantly T-cells in gingivitis to an increased proportion of B-cells 
in periodontitis, susceptibility to periodontal disease progression may 
involve a predominantly TH2-like response. In contrast to these studies, 
Ebersole and Taubman(26) found that IFN-γ message was prominently 
expressed by disease gingival tissue cells. Cytokine profiles of cells ex-
tracted from six patients were consistent with TH1 cells in that they were 
IL-2 and IFN-γ-positive but negative for IL-4 and IL-5.   
 Another study comparing the local and systemic responses in 
periodontitis patients with so-called terminal dentition periodontitis dem-
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in mucosa associated lymphoid tissue, while in secondary lymphoid 
organs, TGF-β may be provided by T cells themselves as suggested 
by recent findings(48). The role of TGF-β in the development of these 
cells is particularly interesting, as TFG-β is also important for driving 
the generation of Treg cell. Thus, TFG-β will promote the differentiation 
of inhibitory Treg; however, in the presence of additional inflammatory 
signals such as IL-6, TH17 cells will be generated. Thus, IL-6 represent 
a crucial switch for controlling the differentiation of CD4+ T cells to the 
TH17 or Treg lineages(34).
 The relationship between TH17 and Treg cells, suggest that 
there is not only a functional antagonism but there is a dichotomy in 
their generation as well(34). Therefore, Treg cells and TH17 effector arise 
in a mutually exclusive fashion, depending on whether they are acti-
vated in the presence of TGF-β or TGF-β plus IL-6. At the steady-state 
level or in the absence of any inflammatory insult, TGF-β produced by 
the immune system will suppress the generation of effector T cells and 
will induce Foxp3+ regulatory T cells thereby maintaining self-tolerance. 
However, on infection or inflammation, IL-6 induced by the activated 
innate immune system will suppress the generation of TGF-β-induced 
Treg cells and will induce a pro-inflammatory T-cell response predomi-
nated by TH17 cells. This is consistent with the in vivo observation that 
destructive arthritis in IFN-γ-deficient mice can be treated with anti-IL-
17, and neutralization of IL-17 results in the generation of CD24+CD25+ 
regulatory T cells(49). So the balance between TH17 and Treg may be 
important in the development/prevention of inflammatory and autoim-
mune diseases(50). 
TH17, Treg cells and IL-17 in periodontitis
 The infiltrate present in periodontal diseases contains mono-
nuclear cells, mainly transmigrated mononuclear phagocytes and 
lymphocytes(51). Previous studies demonstrated the presence and the 
role of IL-17 in the pathogenesis of periodontitis(52,53,54). Vernal et al.(55) 
studied the levels of IL-17 in patients with chronic periodontitis and 
found that they were significantly increased in both gingival crevicular 
fluid and in supernatants of cellular cultures of gingival tissue, compared 
with the control group. Johnson et al.(52) demonstrated a positive correla-
tion between levels of IL-17 within solubilised gingival biopsies and the 
progression of gingivitis to periodontitis. IL-17 treatment of human gin-
gival fibroblast has also been observed to lead to IL-6 production, which 
may contribute to local inflammation(55). Takahashi et al.(53) suggest that 
tissue destruction in periodontitis lesion results from major secretion of 
IL-6, induced by IL-17. The above findings have led to the suggestion 
that IL-17 may play a pivotal role in the initiation or maintenance of an 
inflammatory response.
 Natural Treg are key regulators of immune responses, express 
CD4 and CD25 surface markers, and regulate the activation, prolifera-
tion, and effector function of activated conventional T cells. Previous 
studies found that many of the CD4+ T-cell clones derived from either 
gingival tissue or peripheral blood express the Foxp3 gene(56,57). Okui et 
al. (58) showed that Foxp3+ cells were also identified in periodontitis le-
sions. The cells were restricted to the CD4+ populations.
Final Considerations
 Several investigators have tried to establish the predominant 
T helper profile during periodontitis. Although there has not been con-
sensus about it, in the majority of the literature it was accepted that 
a Th1 profile could be mediator of the early/stable lesion, and a Th2 
profile could be responsible of the progression of the disease. With the 
discovery of the Th17 response, new insights have been made in the 
pathogenesis of the periodontitis, suggesting that Th17 population may 
play a major role in the initiation and maintenance of the inflammatory 
response typical of this disease. 
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onstrated reduced TH2 responses. Levels of prostaglandin E2 (PGE2), 
IL-1β and IL-2 in the gingival crevicular fluid samples were highest, fol-
lowed by lower levels of TNF-α and IFN-γ and even lower of IL-4 and 
IL-6(27).
TH17 cells and IL-17
 In light of recent data, the TH1/TH2 dichotomy is now being 
revisited. The discovery of the IL-17 family of cytokines and the analysis 
of IL-23-mediated effector functions on T cells have suggested the ex-
istence of an additional subset of CD4+ T cells that produce IL-17(28,29). 
During the past few years, it has become apparent that IL-12, STAT4 
and IFN-γ, and therefore Th1 cells, are not the primary instigators of 
model inflammatory diseases(30). Rather, the pathogenic cells in these 
models of disease are induced in response to signals provided in vivo 
by the IL-12-like cytokine IL-23, and characterized by production of a 
suite of cytokines, chemokines, effector molecules and transcription fac-
tors distinct from that of TH1 cells(29,30,31). One of the genes most highly 
expressed in these effector cells is the proinflammatory cytokine IL-1(29). 
Consequently, they have been termed TH17 cells. These TH17 cells 
have been recognized as key mediators of inflammation and tissue 
damage in several animal models of human diseases(29,30,31). Analogous 
to the central roles played by T-bet and GATA3 in generating TH1 and 
TH2 cells, respectively(32), RORγt is considered to be the transcription 
factor responsible for guiding the development of TH17 cells(33), Trans-
forming growth factor β (TGF-β) and IL-6 are cytokines that also guiding 
the development of TH17 cells(34). The role of TH17 cells is very impor-
tant for responses against specific pathogens that are poor eliminated 
by TH1 and TH2 responses (Korn et al. 2007).
 Recent studies showed that IL-21 also controls the generation 
of TH17 cells(35,36,37). They showed that IL-21, in combination with TGF-β, 
induces IL-17 production from naive CD4+ T cells. These papers also 
demonstrated that IL-6 or IL-21 could induce TH17 cells themselves to 
produce IL-21. Such endogenous production of IL-21 by TH17 cells ap-
peared to be biologically significant, because the number of IL-17-pro-
ducing cells generated by TGF-β and IL-6 was reduced in the absence 
of IL-21/IL-21R signalling(35,36). Thus, IL-6 can elicit IL-21 production by 
CD4+ cells, which then functions in an autocrine loop to amplify the 
TH17 response in a similar way to IL-4 for Th2 and IFN-γ for TH1. It is 
possible that TH17 cells induced by TGF-β and either IL-6 or IL-21 make 
qualitatively different contributions to the development of inflammation 
depending on the pathogen and affected tissue(38).
 IL-17, or IL-17A, is the founding member of a six-member fa-
mily of cytokines (IL-17 A-F)(39,40). IL-17A and IL-17F are proinflammatory 
cytokines, and have important action over different cells, inducing ex-
pression of cytokines (e.g. IL-6, GM-CSF, G-CSF, IL-1β, TNF), chemo-
kines (e.g. IL-8, MCP-1) and MMPs (41). IL-17 plays a particularly signif-
icant role in regulating neutrophil recruitment and granulopoiesis(39,42).
TH17 and Treg cells
 Recently, CD4+ CD25+ regulatory T cells (Treg) have been 
described as one distinct subset from T cells(43). Pathogenic autoimmu-
nity is controlled in healthy individuals by a specialized subset of T cells 
named Treg cells(44). Treg cell differentiation and function are driven by 
the transcription factor Foxp3 and they have an anti-inflammatory role 
in maintaining tolerance to self components by contact-dependent su-
ppression or releasing anti-inflammatory cytokines such as IL-10 and 
TGF-β(43). Treg cell development is closely related to the generation of 
TH17 cells. TFG-β induces the differentiation of Treg cells(45), whereas 
TFG- β in combination with IL-6(46) or IL-21(35) results in the differentiation 
of TH17 cells.
 The participation of TGF-β, secreted by Treg cells, in the dif-
ferentiation of TH17 cells has been recently evaluated(35). Subsequent-
ly, it was shown that IL-17 production by naïve CD4+ T cells could be 
driven by TGF-β and IL-6(47). It is clear that TGF-β is readily available 
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